Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
Date:5/20/2008
y and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases, the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy and the Society for Surgery of the Alimentary Tract, DDW takes place May 17-22, 2008, at the San Diego Convention Center, San Diego, CA. The meeting showcases approximately 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. For more information, visit http://www.ddw.org.
THE "SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
Statements included herein that are not historical facts are forward-
looking statements. Such forward-looking statements involve a number of
risks and uncertainties and are subject to change at any time. In the event
such risks or uncertainties materialize, Shire's results could be
materially affected. The risks and uncertainties include, but are not
limited to, risks associated with: the inherent uncertainty of
pharmaceutical research, product development including, but not limited to
the successful development of JUVISTA(R) (Human TGFB3) and veleglucerase
alfa (GA-GCB); manufacturing and commercialization including, but not
limited to, the establishment in the market of VYVANSE(TM)
(lisdexamfetamine dimesylate) (Attention Deficit and Hyperactivity Disorder
("ADHD")); the impact of competitive products, including, but not limited
to, the impact of those on Shire's ADHD franchise; patents, including but
not limited to, legal challenges relating to Shire's ADHD franchise;
government regulation and approval, including but not limited to the
expected product approval date of INTUNIV(TM) (guanfacine extended release)
(ADHD); Shire's ability to secure new products for commercialization and/or
development; and other risks and uncertainties detailed from time to time
in Shire plc's fili
'/>"/>
| SOURCE Shire plc Copyright©2008 PR Newswire. All rights reserved |
Related medicine technology :
1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
Post Your Comments:
(Date:5/22/2013)... , May 22, 2013 STEPh, Inc., a ... the launch of their web site ( http://www.stephreports.com ... About STEPh Reports STEPh ... Each STEPh Report assesses the competitive ... projected launch year, company, and specific key issues. STEPh ...
(Date:5/22/2013)... MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) would like ... recent company developments. As Medifirst continues to expand its ... shareholders. Integrating social media into its investor relations strategy, ... post updates on Twitter. The Facebook homepage is Medifirst ... Says CEO Bruce J. Schoengood ...
(Date:5/22/2013)... May 22, 2013 Ranbaxy Laboratories Limited ... Ltd. (hereafter, Daiichi Sankyo), announced on May 22 ... years to address past conduct under prior management ... Daiichi Sankyo continues to support Ranbaxy in ... of the past which led to the investigations ...
Breaking Medicine Technology:Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Medifirst Solutions, Inc. Announces Update To Shareholders 2... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:Diabetics Twice as Likely to Have Hearing Loss; Pennsylvania HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 2Diabetics Twice as Likely to Have Hearing Loss; Pennsylvania HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 3Diabetics Twice as Likely to Have Hearing Loss; Pennsylvania HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 4Diabetics Twice as Likely to Have Hearing Loss; Pennsylvania HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 5Instrumentation Laboratory Receives 510(K) Clearance From FDA and Canadian License for HemosIL(R) D-Dimer HS 500 Assay 2Instrumentation Laboratory Receives 510(K) Clearance From FDA and Canadian License for HemosIL(R) D-Dimer HS 500 Assay 3Instrumentation Laboratory Receives 510(K) Clearance From FDA and Canadian License for HemosIL(R) D-Dimer HS 500 Assay 4(Date:5/23/2013)... (PRWEB) May 23, 2013 911 Signal USA ... expo will begin on May 22 and run through May ... and information about the company's emergency vehicle lights ... new 2013 Dodge Charger at the expo. , The Charger ... on the market and can be seen by visiting 911 ...
(Date:5/22/2013)... 2013 Most women dread cellulite and ... factors, including estrogen being a factor in the formation ... deposits stored and smashed together which create that dimpling ... take a multi-pronged action," says Kathy Heshelow, founder of ... products like Cellulite Whisperer ® that work to ...
(Date:5/22/2013)... Catalyst Exhibits, Inc., an award-winning global ... its website that allows visitors to view a ... immersive, 360-degree, interactive experience. , The new viewing ... virtually experience the exhibit design Catalyst created for St. ... Users have the ability to interact with the hi-resolution ...
(Date:5/22/2013)... San Francisco, CA (PRWEB) May 22, 2013 ... funerals costing $6,500 or more on average, a funeral concierge ... a funeral, among other benefits. Funeral Financials ... With the average household income in the U.S. ... recession according to Sentier Research, the average funeral costs 12.6% ...
(Date:5/22/2013)... MD (PRWEB) May 22, 2013 On a ... Lisa, spent a few hours watching “The Bourne Legacy” at ... While this may seem like a typical activity to many ... This little stretch of respite from their everyday reality has ... Seals Serving DC | MD | VA. , Life changed ...
Breaking Medicine News(10 mins):Health News:911 Signal USA Attends the 2013 Southwest Police Fleet Expo 2Health News:Get Cellulite Under Control Now with Cellulite Whisperer® Products Introduced by Sublime Beauty® 2Health News:Catalyst Exhibits Debuts 360 Degree Virtual Tour of St. Jude Medical Trade Show Booth 2Health News:Funeral Financials Announces Their Top 3 Reasons to Hire a Funeral Concierge 2Health News:Funeral Financials Announces Their Top 3 Reasons to Hire a Funeral Concierge 3Health News:Military Family Finds Respite with Easter Seals 2Health News:Military Family Finds Respite with Easter Seals 3[0] 911 Signal USA Attends the 2013 Southwest Police Fleet Expo[0] Get Cellulite Under Control Now with Cellulite Whisperer® Products Introduced by Sublime Beauty®[0] Catalyst Exhibits Debuts 360 Degree Virtual Tour of St. Jude Medical Trade Show Booth[0] Funeral Financials Announces Their Top 3 Reasons to Hire a Funeral Concierge[0] Military Family Finds Respite with Easter Seals
... Center have found that the reflux and swallowing problems ... and other neurological impairments, may be caused by a ... finding leaves researchers to wonder if these patients truly ... , In a study published in this quarter,s ...
... some cases, parents encourage the habit, U.S. survey shows , , ... American adolescents are getting early and regular exposure to violent ... almost 13 percent of the nation,s estimated 22 million children ... graphic depictions of violence in film, whether in theaters, on ...
... WellPoint, Inc. (NYSE: WLP ) today,announced the ... its Senior,Business and Consumer Business marketing, effective immediately., ... responsible for leading WellPoint,s,Medicare business division and Consumer ... benefit from the unique knowledge of,Medicare and marketing ...
... for HIV do not increase the risk for coronary atherosclerosis, ... study led by the University of Pittsburgh Graduate School of ... of the journal AIDS and available online today. ... with HIV some protection against atherosclerosis hardening of the ...
... in 2003, when seven people who called themselves ... Team Sarcoma Initiative has become an international movement.,More ... Initiative, surpassing the 3,400 who participated last year. ... advocacy groups and medical centers seeking to raise ...
... appropriate patients ... to help them reach ... blood pressure goals, - Single-pill combinations offer effective, convenient medications which ... treatment goals faster, - Diovan HCT and Exforge approvals may benefit patients who are ...
Cached Medicine News:Health News:Researchers find differences in swallowing mechanism of Rett syndrome patients 2Health News:Many Kids Under 15 Watch Violent Movies 2Health News:Many Kids Under 15 Watch Violent Movies 3Health News:WellPoint Appoints Krista A. Bowers as President of Senior Business 2Health News:Long-term HIV treatment may reduce risk for atherosclerosis 2Health News:8,000 People Join the Team Sarcoma Initiative to Fight a Rare Cancer 2Health News:8,000 People Join the Team Sarcoma Initiative to Fight a Rare Cancer 3Health News:8,000 People Join the Team Sarcoma Initiative to Fight a Rare Cancer 4Health News:8,000 People Join the Team Sarcoma Initiative to Fight a Rare Cancer 5Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 2Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 3Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 4Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 5Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 6Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 7Researchers find differences in swallowing mechanism of Rett syndrome patientsMany Kids Under 15 Watch Violent Movies WellPoint Appoints Krista A. Bowers as President of Senior BusinessLong-term HIV treatment may reduce risk for atherosclerosis8,000 People Join the Team Sarcoma Initiative to Fight a Rare CancerSingle-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
... is designed for rigid skeletal ... greater freedom in positioning the ... skeletal fixation is designed for ... sitting positions. Craniotomies can be ...
Endoscopes...
... borescopes are rigid endoscopes for general applications and ... The diameters of borescopes, i.e. rigid endoscopes, range ... directions from 0 up to a 120 retrospection, ... and wide angle view. Endoscopes with working lengths ...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |